The long term outcome of clinical trial-based treatment comparing standard treatment for metastatic breast cancer.

Standard Treatment ◽

Metastatic Breast ◽

Term Outcome ◽

Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab

The Breast ◽

10.1016/j.breast.2015.09.008 ◽

2015 ◽

Vol 24 (6) ◽

pp. 751-757 ◽

Cited By ~ 15

Author(s):

B. Yeo ◽

K. Kotsori ◽

K. Mohammed ◽

G. Walsh ◽

I.E. Smith

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Her2 Positive ◽

Term Outcome ◽

5000 ORAL Long-term Outcome of HER2-positive (HER2+) Metastatic Breast Cancer (MBC) Patients (pts) Achieving Durable Complete Remission (DCR) After Trastuzumab (T)-containing Chemotherapy (CT)

European Journal of Cancer ◽

10.1016/s0959-8049(11)71442-3 ◽

2011 ◽

Vol 47 ◽

pp. S329-S330 ◽

Cited By ~ 2

Author(s):

G. Gullo ◽

M. Zuradelli ◽

F. Kelleher ◽

F. Sclafani ◽

N. O' Donovan ◽

...

Keyword(s):

Breast Cancer ◽

Complete Remission ◽

Metastatic Breast ◽

Her2 Positive ◽

Term Outcome ◽

Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: Is there a survival benefit?

The Breast ◽

10.1016/j.breast.2017.02.003 ◽

2017 ◽

Vol 32 ◽

pp. 162-172 ◽

Cited By ~ 13

Author(s):

Tae Gon Yoo ◽

Isaac Cranshaw ◽

Reuben Broom ◽

Sanjay Pandanaboyana ◽

Adam Bartlett

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Liver Resection ◽

Survival Benefit ◽

Metastatic Breast ◽

Term Outcome ◽

Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases

International Journal of Clinical Oncology ◽

10.1007/s10147-011-0312-5 ◽

2011 ◽

Vol 17 (5) ◽

pp. 470-476 ◽

Cited By ~ 9

Author(s):

Nobuaki Matsubara ◽

Kuniaki Itoh ◽

Hirofumi Mukai ◽

Shunji Nagai

Keyword(s):

Breast Cancer ◽

Risk Model ◽

Metastatic Breast ◽

Term Outcome ◽

Abstract P4-12-15: Long term outcome with trastuzumab in HER2-positive metastatic breast cancer: A retrospective analysis at The Royal Marsden Hospital, with a median 6 years follow up

10.1158/0008-5472.sabcs13-p4-12-15 ◽

2013 ◽

Author(s):

BJ Yeo ◽

K Kotsori ◽

SRD Johnston ◽

I Smith

Keyword(s):

Breast Cancer ◽

Retrospective Analysis ◽

Metastatic Breast ◽

Her2 Positive ◽

Term Outcome ◽

Long Term Outcome ◽

Royal Marsden Hospital

Long-Term Outcome of Patients (Pts) with Her2-Positive (Her2+) Metastatic Breast Cancer (Mbc) Who Achieved a Complete Response (Cr) After Antiher2 Therapy (Her2Tx)

Annals of Oncology ◽

10.1093/annonc/mdu329.25 ◽

2014 ◽

Vol 25 ◽

pp. iv124

Author(s):

G. Gullo ◽

A. De Giorgi ◽

N. O'Donovan ◽

D. Fennelly ◽

J. Walshe ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Complete Response ◽

Her2 Positive ◽

Term Outcome ◽

Long-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy and Transplantation of Purified Autologous Hematopoietic Stem Cells

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2011.07.009 ◽

2012 ◽

Vol 18 (1) ◽

pp. 125-133 ◽

Cited By ~ 26

Author(s):

Antonia M.S. Müller ◽

Holbrook E.K. Kohrt ◽

Steven Cha ◽

Ginna Laport ◽

Jared Klein ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cells ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Term Outcome ◽

Hematopoietic Stem ◽

Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis

BMC Cancer ◽

10.1186/1471-2407-11-131 ◽

2011 ◽

Vol 11 (1) ◽

Cited By ~ 55

Author(s):

Sibylle Loibl ◽

Tomas Skacel ◽

Valentina Nekljudova ◽

Hans Joachim Lück ◽

Matthias Schwenkglenks ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Dose Intensity ◽

Pooled Analysis ◽

Term Outcome ◽

Long Term Outcome ◽

Short And Long Term ◽

The Impact

Long-term outcome and success for new risk models of pleurodesis in metastatic breast cancer: An analysis of 75 cases.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e11033 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e11033-e11033

Author(s):

N. Matsubara ◽

K. Ito ◽

S. Nagai ◽

H. Mukai

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Risk Models ◽

Term Outcome ◽

Long-term outcome data for patients with HER2- positive early-stage breast cancer treated with adjuvant trastuzumab: Benefit outside clinical trial setting

Annals of Breast Cancer ◽

10.33582/2640-8198/1002 ◽

2018 ◽

Vol 1 (1) ◽

Author(s):

Quintyne KI ◽

◽

Woulfe B ◽

Coffey JC ◽

Gupta RK ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Early Stage ◽

Outcome Data ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Term Outcome ◽

Long Term Outcome ◽

Trial Setting